Immunogenetic and microbial factors in acute anterior uveitis. 1997

D J Careless, and B Chiu, and T Rabinovitch, and J Wade, and R D Inman
University of Toronto, Canada.

OBJECTIVE To characterize the rheumatic diseases associated with acute anterior uveitis and examine the potential role of Yersinia enterocolitica in the pathogenesis of acute anterior uveitis. METHODS 44 patients with acute anterior uveitis were assessed for evidence of an underlying rheumatic syndrome by history and examination. HLA profiles were identified by serologic and molecular techniques. Serological analysis of patients' sera for the presence of antibodies to Y. enterocolitica was by Western blot. RESULTS 30 of the 44 patients had musculoskeletal symptoms. Of these, 8 had ankylosing spondylitis, 4 reactive arthritis, 2 undifferentiated spondyloarthropathy (SpA), 2 inflammatory bowel disease, one seronegative polyarthritis, and 13 mechanical back pain. Of 42 patients typed, 29 (69%) were HLA B27 positive and an additional 7 patients expressed a crossreactive group antigen (86% of total group B27 or CREG positive). Western blot analysis of the sera revealed increased frequency of antibodies to Yersinia compared with a control population. Antibodies directed against the 36 and 27 kDa Yersinia antigens were recognized with greater frequency (p < 0.05) in patients with acute anterior uveitis than in controls. IgG reactivity was more pronounced than IgA reactivity. Adsorption studies showed significant cross reactivity of anti-Yersinia antibodies with Salmonella typhimurium. Among the patients with acute anterior uveitis anti-Yersinia reactivity did not correlate with the HLA profile, nor with the presence of an underlying rheumatic disease. CONCLUSIONS SpA represent the commonest underlying rheumatic disorders associated with acute anterior uveitis. The majority of patients with acute anterior uveitis possess HLA-B27 regardless of whether there is underlying SpA. Patients with acute anterior uveitis show increased frequency of anti-Yersinia antibodies compared with controls. Many of these antibodies appear to be directed against antigenic determinants shared among gram negative bacteria and thus cannot constitute definitive evidence for a causal role specifically for Yersinia in acute anterior uveitis. Acute anterior uveitis represents an interplay of host susceptibility and microbial triggers, as is the case for the SpA in general.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009140 Musculoskeletal Diseases Diseases of the muscles and their associated ligaments and other connective tissue and of the bones and cartilage viewed collectively. Orthopedic Disorders,Musculoskeletal Disease,Orthopedic Disorder
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

D J Careless, and B Chiu, and T Rabinovitch, and J Wade, and R D Inman
January 1987, Vestnik oftalmologii,
D J Careless, and B Chiu, and T Rabinovitch, and J Wade, and R D Inman
July 1988, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology,
D J Careless, and B Chiu, and T Rabinovitch, and J Wade, and R D Inman
August 2009, BMJ (Clinical research ed.),
D J Careless, and B Chiu, and T Rabinovitch, and J Wade, and R D Inman
April 2010, BMJ clinical evidence,
D J Careless, and B Chiu, and T Rabinovitch, and J Wade, and R D Inman
June 2003, Clinical evidence,
D J Careless, and B Chiu, and T Rabinovitch, and J Wade, and R D Inman
June 2002, Clinical evidence,
D J Careless, and B Chiu, and T Rabinovitch, and J Wade, and R D Inman
December 2003, Clinical evidence,
D J Careless, and B Chiu, and T Rabinovitch, and J Wade, and R D Inman
December 2005, Clinical evidence,
D J Careless, and B Chiu, and T Rabinovitch, and J Wade, and R D Inman
December 2004, Clinical evidence,
D J Careless, and B Chiu, and T Rabinovitch, and J Wade, and R D Inman
February 2010, Praxis,
Copied contents to your clipboard!